BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25456742)

  • 21. Autonomous requirements of the Menkes disease protein in the nervous system.
    Hodgkinson VL; Zhu S; Wang Y; Ladomersky E; Nickelson K; Weisman GA; Lee J; Gitlin JD; Petris MJ
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C660-8. PubMed ID: 26269458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favorably skewed X-inactivation accounts for neurological sparing in female carriers of Menkes disease.
    Desai V; Donsante A; Swoboda KJ; Martensen M; Thompson J; Kaler SG
    Clin Genet; 2011 Feb; 79(2):176-82. PubMed ID: 20497190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in ATP7A gene expression underlie intrafamilial variability in Menkes disease/occipital horn syndrome.
    Donsante A; Tang J; Godwin SC; Holmes CS; Goldstein DS; Bassuk A; Kaler SG
    J Med Genet; 2007 Aug; 44(8):492-7. PubMed ID: 17496194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy.
    Kaler SG; Holmes CS
    Adv Pharmacol; 2013; 68():223-33. PubMed ID: 24054147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome.
    Tümer Z
    Hum Mutat; 2013 Mar; 34(3):417-29. PubMed ID: 23281160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mice with mottled mutation--a model for defective copper metabolism in humans].
    Lenartowicz M
    Postepy Hig Med Dosw; 1998; 52(5):527-41. PubMed ID: 9857676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From gene to disease; Menkes disease: copper deficiency due to an ATP7A-gene defect].
    Aldenhoven M; Klomp LW; van Hasselt PM; de Koning TJ; Visser G
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2266-70. PubMed ID: 17987894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders.
    Fieten H; Gill Y; Martin AJ; Concilli M; Dirksen K; van Steenbeek FG; Spee B; van den Ingh TS; Martens EC; Festa P; Chesi G; van de Sluis B; Houwen RH; Watson AL; Aulchenko YS; Hodgkinson VL; Zhu S; Petris MJ; Polishchuk RS; Leegwater PA; Rothuizen J
    Dis Model Mech; 2016 Jan; 9(1):25-38. PubMed ID: 26747866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A serine-to-proline mutation in the copper-transporting P-type ATPase gene of the macular mouse.
    Mori M; Nishimura M
    Mamm Genome; 1997 Jun; 8(6):407-10. PubMed ID: 9166584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked recessive Menkes disease: identification of partial gene deletions in affected males.
    Poulsen L; Horn N; Heilstrup H; Lund C; Tümer Z; Møller LB
    Clin Genet; 2002 Dec; 62(6):449-57. PubMed ID: 12485192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional knockout of the Menkes disease copper transporter demonstrates its critical role in embryogenesis.
    Wang Y; Zhu S; Weisman GA; Gitlin JD; Petris MJ
    PLoS One; 2012; 7(8):e43039. PubMed ID: 22900086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R.
    Tang J; Donsante A; Desai V; Patronas N; Kaler SG
    Mol Genet Metab; 2008 Nov; 95(3):174-81. PubMed ID: 18752978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel ATP7A gross deletion mutation in a Korean patient with Menkes disease.
    Park HD; Moon HK; Lee J; Lee M; Lee SY; Kim JW; Ki CS
    Ann Clin Lab Sci; 2009; 39(2):188-91. PubMed ID: 19429807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked Menkes disease: first documented report of germ-line mosaicism.
    Poulsen L; Møller LB; Plunkett K; Belmont J; Tümer Z; Horn N
    Genet Test; 2004; 8(3):286-91. PubMed ID: 15727253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental expression of the mouse mottled and toxic milk genes suggests distinct functions for the Menkes and Wilson disease copper transporters.
    Kuo YM; Gitschier J; Packman S
    Hum Mol Genet; 1997 Jul; 6(7):1043-9. PubMed ID: 9215673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Menkes P-type ATPase involved in copper homeostasis in the central nervous system of the rat.
    Qian Y; Tiffany-Castiglioni E; Harris ED
    Brain Res Mol Brain Res; 1997 Aug; 48(1):60-6. PubMed ID: 9379850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of copper accumulation in cell lines established from nine different alleles of mottled are the same as those found in Menkes disease.
    Masson W; Hughes H; Papworth D; Boyd Y; Horn N
    J Med Genet; 1997 Sep; 34(9):729-32. PubMed ID: 9321757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired somatostatin accumulation within the median eminence in mice with mosaic mutation.
    Wojewodzka U; Gajewska A; Gajkowska B; Styrna J; Kochman K
    Neuro Endocrinol Lett; 2004; 25(1-2):78-82. PubMed ID: 15159688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menkes disease.
    Bertini I; Rosato A
    Cell Mol Life Sci; 2008 Jan; 65(1):89-91. PubMed ID: 17989919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.
    de Bie P; Muller P; Wijmenga C; Klomp LW
    J Med Genet; 2007 Nov; 44(11):673-88. PubMed ID: 17717039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.